bpc 157 pancreatic cancer Everyone's talking about peptides like this… so let's actually look at the science. Yes — there is a study on BPC-157 and cancer. But it's a 2004 conference abstract (not even a Recent advances and applications of

The key principle is that any combination therapy should be initiated and monitored under close medical supervision, with dose adjustments made based on glucose monitoring results and individual patient response

But within that delicate, freeze-dried cake lies a formidable research tool: Insulin-like Growth Factor 1 Long Arginine 3, or IGF-1 LR3

2017 Jul 1;5(2):261-8

You love it

PRECAUTIONS Doses of cyanocobalamin exceeding 10 mcg daily may produce hematologic response in patients with folate deficiency

The FDA's Pharmacy Compounding Advisory Committee (PCAC) met July 2324 to evaluate whether specific peptides, including BPC-157, belong on the 503A Bulks List, which is the FDAs roster of substances eligible for pharmaceutical compounding